Leishmaniasis-HIV coinfection: current challenges

Imagem de Miniatura
Arquivos
art_LINDOSO_LeishmaniasisHIV_coinfection_current_challenges_2016.PDF (2.48 MB)
Citações na Scopus
87
Tipo de produção
article
Data de publicação
2016
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
DOVE MEDICAL PRESS LTD
Autores
QUEIROZ, Igor Thiago
MOREIRA, Carlos Henrique Valente
Citação
HIV AIDS-RESEARCH AND PALLIATIVE CARE, v.8, p.147-156, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Leishmaniasis - human immunodeficiency virus (HIV) coinfection can manifest itself as tegumentary or visceral leishmaniasis. Almost 35 countries have reported autochthonous coinfections. Visceral leishmaniasis is more frequently described. However, usual and unusual manifestations of tegumentary leishmaniasis have been reported mainly in the Americas, but the real prevalence of Leishmania infection in HIV-infected patients is not clear. Regarding the clinical manifestations, there are some reports showing unusual manifestations in visceral leishmaniasis and tegumentary leishmaniasis in HIV-infected patients; yet, the usual manifestations are more frequent. Leishmaniasis diagnosis relies on clinical methods, but serological tests are used to diagnose visceral leishmaniasis despite them having a low sensitivity to tegumentary leishmaniasis. The search for the parasite is used to diagnose both visceral leishmaniasis and tegumentary leishmaniasis. Nevertheless, in HIV-infected patients, the sensitivity of serology is very low. Drugs available to treat leishmaniasis are more restricted and cause severe side effects. Furthermore, in HIV-infected patients, these side effects are more prominent and relapses and lethality are more recurrent. In this article, we discuss the current challenges of tegumentary leishmaniasis and visceral leishmaniasis-HIV infection, focusing mainly on the clinical manifestations, diagnosis, and treatment of leishmaniasis.
Palavras-chave
leishmaniasis, HIV infection, coinfection, epidemiology, clinical manifestations, diagnosis, treatment
URI
https://observatorio.fm.usp.br/handle/OPI/20376
Referências
  1. Akilov OE, 2007, INT J DERMATOL, V46, P132
  2. ALBRECHT H, 1994, CLIN INVESTIGATOR, V72, P1041, DOI 10.1007/BF00577752
  3. Aliaga L, 2003, MEDICINE, V82, P147, DOI 10.1097/00005792-200305000-00001
  4. Alonso MJ, 1997, PATHOL RES PRACT, V193, P43
  5. Alvar J, 1997, CLIN MICROBIOL REV, V10, P298
  6. Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07
  7. Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
  8. Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
  9. Amerson EH, 2011, DERMATOL CLIN, V29, P39, DOI 10.1016/j.det.2010.09.007
  10. Angarano G, 1998, J INFECTION, V36, P167, DOI 10.1016/S0163-4453(98)80007-8
  11. Antinori S, 2012, EUR J CLIN MICROBIOL, V31, P109, DOI 10.1007/s10096-011-1276-0
  12. Ara M, 1998, BRIT J DERMATOL, V139, P114
  13. Argaw D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002543
  14. Attar ZJ, 2001, ACTA TROP, V78, P11, DOI 10.1016/S0001-706X(00)00155-8
  15. Balasegaram M, 2012, EXPERT OPIN EMERG DR, V17, P493, DOI 10.1517/14728214.2012.748036
  16. Balkhair A, 2008, INT J INFECT DIS, V12, P111, DOI 10.1016/j.ijid.2007.04.009
  17. Barbosaor WL, 2015, AM J TROP MED HYG, V93, P967, DOI 10.4269/ajtmh.14-0798
  18. BARRAL A, 1995, INT J DERMATOL, V34, P474, DOI 10.1111/j.1365-4362.1995.tb00613.x
  19. BERNIER R, 1995, J VIROL, V69, P7282
  20. BETZ P, 1990, PATHOLOGE, V11, P97
  21. Bogdan C, 2012, ANN RHEUM DIS, V71, P60, DOI 10.1136/annrheumdis-2011-200596
  22. Bosch RJ, 2002, INT J DERMATOL, V41, P670, DOI 10.1046/j.1365-4362.2002.01610.x
  23. Bossolasco S, 2003, J CLIN MICROBIOL, V41, P5080, DOI 10.1128/JCM.41.11.5080-5084.2003
  24. CANOVAS DL, 1994, J LARYNGOL OTOL, V108, P1089
  25. Chrusciak-Talhari A, 2009, AM J TROP MED HYG, V81, P559, DOI 10.4269/ajtmh.2009.09-0077
  26. Colomba C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-199
  27. COSTA JML, 1986, J TROP MED HYG, V89, P319
  28. Cota GF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002816
  29. Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153
  30. Cota GF, 2013, AM J TROP MED HYG, V89, P570, DOI 10.4269/ajtmh.13-0239
  31. Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665
  32. Cunha MA, 2015, AM J TROP MED HYG, V93, P1214, DOI 10.4269/ajtmh.15-0033
  33. del Giudice P, 2002, J INFECT DIS, V186, P1366, DOI 10.1086/344325
  34. Dereure J, 2003, J INFECTION, V47, P77, DOI 10.1016/S0163-4453(03)00002-1
  35. Desjeux P., 1992, World Health Statistics Quarterly, V45, P267
  36. Diro E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004087
  37. Diro E, 2015, LANCET INFECT DIS, V15, P122, DOI 10.1016/S1473-3099(14)70833-3
  38. Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869
  39. Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002875
  40. Ejara ED, 2010, TROP MED INT HEALTH, V15, P1266, DOI 10.1111/j.1365-3156.2010.02612.x
  41. Ezra Navid, 2010, J Glob Infect Dis, V2, P248, DOI 10.4103/0974-777X.68528
  42. Garcia-Garcia JA, 2006, J CLIN MICROBIOL, V44, P4455, DOI 10.1128/JCM.00921-06
  43. Garg R, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000441
  44. Gea-Banacloche JC, 1999, AIDS, V13, pS25
  45. Gonzalez-Beato MJ, 2000, BRIT J DERMATOL, V143, P1316, DOI 10.1046/j.1365-2133.2000.03909.x
  46. Goto H, 2012, INFECT DIS CLIN N AM, V26, P293, DOI 10.1016/j.idc.2012.03.001
  47. Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]
  48. Guerra JAO, 2011, AM J TROP MED HYG, V85, P524, DOI 10.4269/ajtmh.2011.11-0075
  49. Herrador Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003594
  50. HEUDIER P, 1993, PRESSE MED, V22, P1060
  51. Hozannah A, 2013, AN BRAS DERMATOL, V88, P992, DOI 10.1590/abd1806-4841.20132191
  52. Kallel K, 2007, PATHOL BIOL, V55, P521, DOI 10.1016/j.patbio.2007.07.017
  53. Koval CE, 2002, CLIN INFECT DIS, V35, P491, DOI 10.1086/341974
  54. Lima IP, 2013, REV SOC BRAS MED TRO, V46, P156, DOI 10.1590/0037-8682-0033-2012
  55. Lindoso JAL, 2009, BRIT J DERMATOL, V160, P311, DOI 10.1111/j.1365-2133.2008.08908.x
  56. Lindoso JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003136
  57. Lopez-Velez R, 2003, ANN TROP MED PARASIT, V97, P143, DOI 10.1179/000349803225002615
  58. Lopez-Velez R, 2001, CLIN MICROBIOL INFEC, V7, P394, DOI 10.1046/j.1198-743x.2001.00270.x
  59. MACHADO ES, 1992, MEM I OSWALDO CRUZ, V87, P487
  60. Mahajan R, 2015, CLIN INFECT DIS, V61, P1255, DOI 10.1093/cid/civ530
  61. Mattos M, 1998, J EUR ACAD DERMATOL, V10, P218, DOI 10.1111/j.1468-3083.1998.tb00739.x
  62. Molina R, 2003, ANN TROP MED PARASIT, V97, P29, DOI 10.1179/000349803225002516
  63. Monge-Maillo B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003021
  64. Narita M, 1998, AM J RESP CRIT CARE, V158, P157
  65. NUZUM E, 1995, J INFECT DIS, V171, P751
  66. Organization WH, 2010, WHO TECHNICAL REPORT, pxii
  67. Pan American Health Organization WHO, 2013, LEISHM EP REP AM
  68. Pearson R. D., 1999, Current Infectious Disease Reports, V1, P448, DOI 10.1007/s11908-999-0057-8
  69. Pearson RD, 1999, CURR INFECT DIS REP, V1
  70. Posada-Vergara MP, 2005, J INFECT DIS, V192, P1819, DOI 10.1086/497338
  71. Puig L, 2003, ANN TROP MED PARASIT, V97, P107, DOI 10.1179/000349803225002589
  72. Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8
  73. Russo R, 2003, ANN TROP MED PARASIT, V97, P149, DOI 10.1179/000349803225002624
  74. Sakthianandeswaren A, 2009, TRENDS PARASITOL, V25, P383, DOI 10.1016/j.pt.2009.05.004
  75. Sampaio Raimunda Nonata Ribeiro, 2002, Rev. Soc. Bras. Med. Trop., V35, P651, DOI 10.1590/S0037-86822002000600017
  76. Saporito L, 2013, INT J INFECT DIS, V 17, pE572, DOI 10.1016/j.ijid.2012.12.024
  77. Scarisbrick J J, 2006, Travel Med Infect Dis, V4, P14, DOI 10.1016/j.tmaid.2004.11.002
  78. Schleenvoigt BT, 2016, INFECTION, V44, P115, DOI 10.1007/s15010-015-0813-7
  79. Schwartz E, 2006, LANCET INFECT DIS, V6, P342, DOI 10.1016/S1473-3099(06)70492-3
  80. Singh S, 2014, INT J INFECT DIS, V29, P103, DOI 10.1016/j.ijid.2014.07.011
  81. Sinha S, 2008, INT J DERMATOL, V47, P1263, DOI 10.1111/j.1365-4632.2008.03804.x
  82. Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006
  83. Stone S F, 2002, HIV Med, V3, P21, DOI 10.1046/j.1464-2662.2001.00096.x
  84. Turetz ML, 2002, J INFECT DIS, V186, P1829, DOI 10.1086/345772
  85. UNAIDS, WORLD AIDS DAY REP 2
  86. UNAIDS, 2012, GLOB REP UNAIDS REP
  87. van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556
  88. van Griensven J, 2013, LANCET INFECT DIS, V13, P251, DOI 10.1016/S1473-3099(12)70348-1
  89. van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005
  90. WHO, 2010, WHO TECH REP SER, V949, P1
  91. Zijlstra EE, 2016, ARCH DIS CHILD, V101, P561, DOI 10.1136/archdischild-2015-309302

Coleções
Artigos e Materiais de Revistas Científicas - LIM/38
Artigos e Materiais de Revistas Científicas - ODS/03